October 02, 2015
Drug Industry Protections Causing Complications Among Trade Negotiators
International trade ministers met this week in Atlanta and the Wall Street Journal reported that they continue to be divided over provisions related to prescription drugs and how long companies will be able to keep lower-cost generics off the market. Americans already pay the highest prices in the industrialized world for prescription drugs and if the TPP is passed the Alliance and other senior and consumer groups are deeply concerned that the situation will be worse.
“The Alliance team is closely monitoring this issue, and will take appropriate action to ensure that Alliance members’ voices are heard, as should anyone who relies on Medicare or prescription drugs,” said Robert Roach, Jr., President of the Alliance. “We know that free trade deals, especially when they’ve been negotiated in secret, often end up being a bad deal for older Americans and working people.”